Neurofeedback for Attention-Deficit/Hyperactivity Disorder
Rattachement africain : gb, de, it, fr, ch, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Importance: Neurofeedback has been proposed for the treatment of attention-deficit/hyperactivity disorder (ADHD) but the efficacy of this intervention remains unclear. Objective: To conduct a meta-analysis of randomized clinical trials (RCTs) using probably blinded (ie, rated by individuals probably or certainly unaware of treatment allocation) or neuropsychological outcomes to test the efficacy of neurofeedback as a treatment for ADHD in terms of core symptom reduction and improved neuropsychological outcomes. Data Sources: PubMed (MEDLINE), Ovid (PsycInfo, MEDLINE, Embase + Embase Classic), and Web of Science, as well as the reference lists of eligible records and relevant systematic reviews, were searched until July 25, 2023, with no language limits. Study Selection: Parallel-arm RCTs investigating neurofeedback in participants of any age with a clinical ADHD or hyperkinetic syndrome diagnosis were included. Data Extraction and Synthesis: Standardized mean differences (SMDs) with Hedges g correction were pooled in random effects meta-analyses for all eligible outcomes. Main Outcomes and Measures: The primary outcome was ADHD total symptom severity assessed at the first postintervention time point, focusing on reports by individuals judged probably or certainly unaware of treatment allocation (probably blinded). Secondary outcomes were inattention and/or hyperactivity-impulsivity symptoms and neuropsychological outcomes postintervention and at a longer-term follow-up (ie, after the last follow-up time point). RCTs were assessed with the Cochrane risk of bias tool version 2.0. Results: A total of 38 RCTs (2472 participants aged 5 to 40 years) were included. Probably blinded reports of ADHD total symptoms showed no significant improvement with neurofeedback (k = 20; n = 1214; SMD, 0.04; 95% CI, -0.10 to 0.18). A small significant improvement was seen when analyses were restricted to RCTs using established standard protocols (k = 9; n = 681; SMD, 0.21; 95% CI, 0.02 to 0.40). Results remained similar with adults excluded or when analyses were restricted to RCTs where cortical learning or self-regulation was established. Of the 5 neuropsychological outcomes analyzed, a significant but small improvement was observed only for processing speed (k = 15; n = 909; SMD, 0.35; 95% CI, 0.01 to 0.69). Heterogeneity was generally low to moderate. Conclusions and Relevance: Overall, neurofeedback did not appear to meaningfully benefit individuals with ADHD, clinically or neuropsychologically, at the group level. Future studies seeking to identify individuals with ADHD who may benefit from neurofeedback could focus on using standard neurofeedback protocols, measuring processing speed, and leveraging advances in precision medicine, including neuroimaging technology.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Neurofeedback for Attention-Deficit/Hyperactivity Disorder
- Date Crossref
- 01/02/2025
- Éditeur
- American Medical Association (AMA)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
King's College London Department of Psychology pays non établi dans la noticeUniversité ou école supérieure
-
Heidelberg University pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Heidelberg pays non établi dans la noticeÉtablissement de santé
-
Central Institute of Mental Health pays non établi dans la noticeÉtablissement de santé
-
University of Cagliari Department of Biomedical Sciences pays non établi dans la noticeUniversité ou école supérieure
-
Université de Montpellier pays non établi dans la noticeUniversité ou école supérieure
-
Centre Hospitalier Universitaire de Montpellier pays non établi dans la noticeÉtablissement de santé
-
Landschaftsverband Westfalen-Lippe pays non établi dans la noticeInstitution
-
Ruhr University Bochum Department for Child and Adolescent Psychiatry pays non établi dans la noticeUniversité ou école supérieure
-
University of Zurich Department of Child and Adolescent Psychiatry and Psychotherapy pays non établi dans la noticeUniversité ou école supérieure
-
Centre de recherche en Epidémiologie et Santé des Populations pays non établi dans la noticeStructure de recherche
-
ETH Zurich pays non établi dans la noticeUniversité ou école supérieure
Department of Psychology — King's College London, Heidelberg University et University Hospital Heidelberg, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.